Advanz Pharma and Alvotech receive European approval for Mynzepli, Biosimilar to Eylea
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for…
Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth…
QCI Expands Leadership Depth with Strategic Hires with the VizExplorer Integration
SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI)…
Velorgain Expands Cold Storage Solutions to Protect Digital Assets
London, UK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- In the evolving landscape…
XL.net Becomes First Chicago IT Support Firm to Achieve ISO 27001:2022 Certification
XL.net Sets a New Standard in IT Security with ISO 27001:2022 Certification…
Glaucoma Research Foundation Launches Treatment Accelerator with Transformative $5 Million Gift
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation is…
InfoAging Launches Floridas First Comprehensive Care Team Finder to Tackle Senior Health Crisis
August 20, 2025 10:00 ET | Source: InfoAging Miami, Florida, Aug. 20,…
Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy
August 20, 2025 09:48 ET | Source: Keros Therapeutics, Inc. LEXINGTON, Mass.,…
Digitalist Group Oyj – Managers’ Transactions
August 19, 2025 13:48 ET | Source: Digitalist Group Oyj Digitalist Group…
Crown Point Capital Rolls Out Global Investor Protection Program This Quarter
Zurich, Switzerland, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Crown Point Capital has officially…
